OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ACSEL55

Aciselsan Acipayam Seluloz Sanayi ve Ticaret AS

Commodity ChemicalsVerified

Aciselsan maintains a conservative capital structure with a debt-to-equity ratio of 0.26, well below the industry median for Commodity Chemicals. The company's liquidity position is characterized as medium, with a current ratio of 1.1 and free cash flow of 11,275,800 TRY. However, net cash is negative after subtracting total debt, indicating a potential liquidity constraint. Profitability metrics show a return on equity of 2.94% and a return on assets of 1.84%, both below the industry median for Commodity Chemicals. The operating margin is 14.5%, and the net margin is 5.8%, which are in line with the industry average. The company's gross margin of 17.8% is slightly below the median, suggesting moderate cost pressures. The company's revenue is concentrated in Turkey, with no disclosed international operations. The business is primarily driven by the textile and paper industries, which are sensitive to macroeconomic conditions and raw material price fluctuations. Looking ahead, the company is projected to grow revenue by 3.5% in the current fiscal year and 2.1% in the next fiscal year. This growth is modest compared to the industry average of 5.0% and is driven by stable demand in the domestic market. Capital expenditure is expected to remain negative, indicating a focus on cost optimization rather than expansion. The risk assessment highlights a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued new shares in the past year. The risk of dilution is further mitigated by the absence of at-the-market (ATM) or shelf registration programs. Recent filings and transcripts indicate no material changes in the company's operations or strategy. The company continues to focus on cost control and operational efficiency, with no significant capital projects or strategic acquisitions disclosed in the latest reports.

30-day price · ACSEL+37.20 (+34.9%)
Low$105.50High$169.40Close$143.90As of15 May, 00:00 UTC
Profile
CompanyAciselsan Acipayam Seluloz Sanayi ve Ticaret AS
TickerACSEL.IS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Aciselsan Acipayam Seluloz Sanayi ve Ticaret AS produces and distributes cellulose and related chemical products, primarily serving the textile and paper industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Aciselsan maintains a conservative capital structure with a debt-to-equity ratio of 0.26, well below the industry median for Commodity Chemicals. The company's liquidity position is characterized as medium, with a current ratio of 1.1 and free cash flow of 11,275,800 TRY. However, net cash is negative after subtracting total debt, indicating a potential liquidity constraint. Profitability metrics show a return on equity of 2.94% and a return on assets of 1.84%, both below the industry median for Commodity Chemicals. The operating margin is 14.5%, and the net margin is 5.8%, which are in line with the industry average. The company's gross margin of 17.8% is slightly below the median, suggesting moderate cost pressures. The company's revenue is concentrated in Turkey, with no disclosed international operations. The business is primarily driven by the textile and paper industries, which are sensitive to macroeconomic conditions and raw material price fluctuations. Looking ahead, the company is projected to grow revenue by 3.5% in the current fiscal year and 2.1% in the next fiscal year. This growth is modest compared to the industry average of 5.0% and is driven by stable demand in the domestic market. Capital expenditure is expected to remain negative, indicating a focus on cost optimization rather than expansion. The risk assessment highlights a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued new shares in the past year. The risk of dilution is further mitigated by the absence of at-the-market (ATM) or shelf registration programs. Recent filings and transcripts indicate no material changes in the company's operations or strategy. The company continues to focus on cost control and operational efficiency, with no significant capital projects or strategic acquisitions disclosed in the latest reports.
Key takeaways
  • Aciselsan maintains a conservative capital structure with a debt-to-equity ratio of 0.26.
  • The company's profitability metrics are below the industry median, with a return on equity of 2.94%.
  • Revenue is concentrated in Turkey, with no disclosed international operations.
  • The company is projected to grow revenue by 3.5% in the current fiscal year.
  • The risk of dilution is low, with no new share issuance in the past year.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$214.8M
Gross profit$38.2M
Operating income$31.2M
Net income$12.4M
R&D
SG&A
D&A
SBC
Operating cash flow$7.9M
CapEx-$3.3M
Free cash flow$11.3M
Total assets$675.2M
Total liabilities$252.1M
Total equity$423.1M
Cash & equivalents$7.6M
Long-term debt$109.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$111.0M$30.1M$35.1M$34.0M
FY-3$644.0M$74.7M$65.1M$49.1M
FY-2$644.8M$67.4M$51.7M-$202.5M
FY-1$890.0M$13.1M-$47.3M-$43.7M
FY0$685.8M-$15.2M-$67.2M-$39.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$128.6M$89.6M$9.5M
FY-3$468.8M$327.0M$10.00
FY-2$812.7M$519.7M$10.00
FY-1$1.06B$631.7M$5.9M
FY0$941.3M$575.0M$21.1M
PeriodOCFCapExFCFSBC
FY-4$5.5M-$801.8k$34.0M
FY-3-$75.1M-$17.5M$49.1M
FY-2$227.0M-$258.5M-$202.5M
FY-1-$60.5M-$19.1M-$43.7M
FY0$88.3M-$10.4M-$39.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$214.8M$31.2M$12.4M$11.3M
FQ-6$192.0M-$48.9M-$11.2M-$13.6M
FQ-5$213.5M-$25.3M-$38.3M-$28.1M
FQ-4$255.7M$56.3M-$10.5M-$10.5M
FQ-3$104.4M-$27.5M-$29.3M-$22.2M
FQ-2$140.6M-$1.6M-$26.5M-$20.3M
FQ-1$216.2M-$11.4M-$6.7M$861.2k
FQ0$211.7M$27.2M-$1.6M$5.5M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$675.2M$423.1M$7.6M
FQ-6$735.3M$450.0M$10.00
FQ-5$818.3M$461.3M$10.00
FQ-4$1.06B$631.7M$5.9M
FQ-3$805.3M$501.9M$0.00
FQ-2$852.9M$506.6M$1.7M
FQ-1$892.7M$539.8M$7.0M
FQ0$941.3M$575.0M$21.1M
PeriodOCFCapExFCFSBC
FQ-7$7.9M-$3.3M$11.3M
FQ-6$28.0M-$10.1M-$13.6M
FQ-5-$162.4M-$9.2M-$28.1M
FQ-4-$60.5M-$19.1M-$10.5M
FQ-3$3.8M-$781.8k-$22.2M
FQ-2$11.4M-$3.5M-$20.3M
FQ-1$21.7M-$6.3M$861.2k
FQ0$88.3M-$10.4M$5.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$423.1M
Net cash-$101.6M
Current ratio1.1
Debt/Equity0.3
ROA1.8%
ROE2.9%
Cash conversion63.0%
CapEx/Revenue-1.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricACSELActivity
Op margin14.5%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin5.8%4.1% medp25 0.1% · p75 8.8%above median
Gross margin17.8%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-1.5%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity26.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 06:14 UTC#7aa1da68
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 06:27 UTCJob: 8757d4ee